ÉèÍòά¶ÁÕßΪÊ×Ò³ ¹ã¸æ·þÎñ ÁªÏµÎÒÃÇ ¹ØÓÚÍòά
¼òÌå ·±Ìå ÊÖ»ú°æ
Ê×Ò³ ÐÂÎÅ ÊÓÆµ ²©¿Í ÂÛ̳ ·ÖÀà¹ã¸æ ¹ºÎï
°æÖ÷£º°¢·ÉµÄ½£
Íòά¶ÁÕßÍø > ÜøÏã²èÓï > Ìû×Ó
NIHÔç¾ÍÖªµÀADE
Ëͽ»Õß: ÂÌÒ°ÏÉÈË 2021Äê08ÔÂ08ÈÕ13:33:05 ÓÚ [ÜøÏã²èÓï] ·¢ËÍÇÄÇÄ»°

NIHÔç¾ÍÖªµÀADEÊÇÕæµÄ¡£ pifuÊÇ¡°²¡¶¾×¨¼Ò¡±¡£´ó¼ÒÇëËý¸ø½âÊÍһϡ£

ËýÔÚÕâÀïÊýÄêÈçÒ»Èյع¥»÷·´ÒßÃçµÄÈË¡£

ËýÊýÄêÈçÒ»ÈÕÍÆÏúÒßÃç¡£

ÊDz»ÊǸøø´ó¼Ò˵Ã÷Ò»ÏÂÁË¡£

Èç¹ûÄãÃǼÌÐøÈÃËýÔÚÕâÀïÈö»Ñ£¬ÄÇôÄãÃÇËÀÁ˶¼ÊÇ»î¸Ã¡£

¼ÇסÊÇʲôÈ˺¦ÄãÃǵġ£ÊÇʲôÈËÒ»Ö±ÔÚÏë°ì·¨ÈÃÄãÃǾõÐÑ£¡£¡£¡£¡±ð¸ã´íÁË¡£

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645850/

Informed consent disclosure to vaccine trial subjects of risk of COVID©19 vaccines worsening clinical disease

3. CONCLUSION

Given the strong evidence that ADE is a non©theoretical and compelling risk for COVID©19 vaccines and the ¡°laundry list¡± nature of informed consents, disclosure of the specific risk of worsened COVID©19 disease from vaccination calls for a specific, separate, informed consent form and demonstration of patient comprehension in order to meet medical ethics standards. The informed consent process for ongoing COVID©19 vaccine trials does not appear to meet this standard. While the COVID©19 global health emergency justifies accelerated vaccine trials of candidates with known liabilities, such an acceleration is not inconsistent with additional attention paid to heightened informed consent procedures specific to COVID©19 vaccine risks.


0%(0)
¡¡¡¡¡¡¡¡¡¡¡¡ß@·N‘B¶Èï@È»²»ÊǿƌWÀíÐԵġ£¡¡¡¡/ÎÞÄÚÈÝ - ¿ÕÐÐ 08/09/21 (230)
¡¡¡¡¡¡¡¡¡¡¡¡»¹ÓÐCnoversea¾®ÍÜÇØ´¨ÐÂÒ°µÈÈË£¬×¨ÃÅÔìÒ¥£¬ÒÔ°¤ÂîΪÀÖ¡¡¡¡/ÎÞÄÚÈÝ - ±±ÃÀÅóÓÑ 08/09/21 (239)
¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡ÂÌÒ°ÏÉÈËÔìʲôҥ£¿¿ÖÅÂÊǽÒ¶ÒßÃçÕæÏàÓ°ÏìÄãµÄÊÕÈë°É£¡¡¡¡¡/ÎÞÄÚÈÝ - ¿ÕÐÐ 08/09/21 (242)
±ê Ìâ (±ØÑ¡Ïî):
ÄÚ ÈÝ (Ñ¡ÌîÏî):
ʵÓÃ×ÊѶ
»Ø¹ú»úƱ$360Æð | ÉÌÎñ²ÕÊ¡$200 | È«Çò×î¼Ñº½¿Õ¹«Ë¾³ö¯£ºº£º½»ñÎåÐÇ
º£Í⻪È˸£Àû£¡ÔÚÏß¿´³Â½¨±ó¡¶Èý²æêª¡·ÈÈѪ¹é»Ø ºÀÇéÖþÃÎ ¸ßÇåÃâ·Ñ¿´ ÎÞµØÇøÏÞÖÆ